UNH shares have experienced heavy selling pressure since reporting, dropping over 20%, but a 9% post-market rally on CMS rate news and elevated options volume have fueled retests of breakout support levels, while the long-term uptrend remains intact.

Medicare Advantage payments were finalized with a 2.48% increase, delivering about $13 billion in additional 2027 revenue for insurers, while UnitedHealth posted 12.3% revenue growth to $113.2 billion in Q4 and nearly $448 billion for 2025. Management plans deliberate revenue exits of unprofitable contracts under a margin recovery program, targeting over $17.75 adjusted EPS and ~$1 billion in AI-driven cost reductions in FY2026, alongside $1.6 billion AI investments to rebuild Optum margins and drive operating earnings back to $24 billion.

2027 Medicare Advantage rates were finalized at a 2.48% increase—reversing a near-flat January proposal—and CMS will eliminate 11 Star Ratings metrics from the 2027 measurement period, freeing over $18 billion for insurers. The government postponed an overhaul of MA payment calculations, maintaining current methodologies. Meanwhile, the federal funds rate has eased from 4.5% to 3.75%, lowering borrowing costs amid heightened regulatory scrutiny, including DOJ oversight.

Unexpected Medicare Advantage rate increases have reignited investor confidence, prompting bullish upgrades and narratives of AI-driven cost savings and margin recovery, while lingering caution around near-term earnings guidance, regulatory scrutiny, and medical cost volatility tempers enthusiasm.